Nanyang Biologics Enters $1.5B Agreement to Go Public via RF Acquisition Corp II Nanyang Biologics Pte. Ltd. announces its $1.5 billion deal with RF Acquisition Corp II, aiming for a public listing to revolutionize drug discovery.

Nanyang Biologics Enters $1.5B Agreement to Go Public via RF Acquisition Corp II #Singapore #Drug_Discovery #Nanyang_Biologics #RF_Acquisition

The9's Investee Nanyang Biologics to Go Public on Nasdaq Through $1.5 Billion Merger The9 Limited's Singapore investment, Nanyang Biologics, plans a significant merger with RF Acquisition Corp II, targeting a Nasdaq listing valued at $1.5 billion.

The9's Investee Nanyang Biologics to Go Public on Nasdaq Through $1.5 Billion Merger #NASDAQ #Singapore #The9_Limited #Nanyang_Biologics